Recent developments in obstetrics

British Medical Journal

Volumn 327, Issue 7415, 2003, Pages 604-608

  Shennan, Andrew H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ATOSIBAN; CALCIUM CHANNEL BLOCKING AGENT; CLINDAMYCIN; CYCLOOXYGENASE 2 INHIBITOR; ERYTHROMYCIN; FISH OIL; MAGNESIUM SULFATE; METRONIDAZOLE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROGESTERONE;

BREECH PRESENTATION; CESAREAN SECTION; DOPPLER FLOWMETRY; FETUS DISEASE; GYNECOLOGIC INFECTION; HUMAN; KIDNEY DISEASE; LOW BIRTH WEIGHT; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREMATURITY; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SCAR; SIDE EFFECT; SKIN SCAR; TREATMENT OUTCOME; UTERINE ARTERY; UTERINE CERVIX CERCLAGE;

EID: 0141836156     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.327.7415.604     Document Type: Review

References (35)

1. Mires GJ, Williams FI, Leslie J, Howie PW. Assessment of uterine arterial notching as a screening test for adverse pregnancy outcome. Am J Obstet Gynecol 1998;179:1317-23.
2. Coleman MA, McCowan LM, North RA. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high risk women. Ultrasound Obstet Gynecol 2000;15:4-6.
3. Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet durgs for prevention of pre-eclampsia and is consequences: systematic review. BMJ 2001;322:329-33.
4. Knight M, Duley L, Henderson-Smart DJ, King JF. Antiplatelet agents for preventing and treating pre-eclampsia. Cochrane Database Syst Rev 2000;(2):CD000492.
5. Coomarasamy A, Papaioannou S, Gee H, Khan KS. Aspirin for the prevention of pre-eclampsia in women with abnormal uterine artery Doppler: a meta-analysis. Obstet Gynaecol 2001;98:861-6.
6. Chappell LC, Seed PT, Briley AL, Kelly FJ, Hunt BJ, Parmar K, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999;354:810-6.
7. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2001;(2):CD002252.
8. Confidential Enquiry into Maternal Deaths in the United Kingdom. Why mothers die, report for 1997-1999. London: RCOG Press, 2001.
9. Which anti-convulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 1995;345:1455-63.
10. Duley L. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial: a randomised placebo-controlled trial. Lancet 2002;359:1877-90.
11. Hassan SS, Romero R, Berry SM, Dang K, Blackwell SC, Treadwell MC, et al. Patients with an ultrasonographic cervical length < or = 15 mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol 2000;182:1458-67.
12. Guzman ER, Walters C, O'Reilly-Green C, Meirowitz NB, Gipson K, Nigam J, et al. Use of cervical ultrasonography in prediction of spontaneous preterm birth in triplet gestations. Am J Obstet Gynecol 2000;183:1108-13.
13. Heath VC, Daskalakis G, Zagaliki A, Carvalho M, Nicolaides KH. Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early pre-term delivery. Br J Obstet Gynaecol 2000;107:1276-81.
14. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. Br J Obstet Gynaecol 2001;108:133-42.
15. Althuisius SM, Dekker GA, van Geijn HP, Bekedam D, Kuik D, van Geijn H. Cervical incompetence prevention randomized cerclage trial (CIPRACT): study design and preliminary results. Am J Obstet Gynecol 2001;183:823-9.
16. David G, Berghella V, Talucci M, Wapner RJ. Patients with a prior failed transvaginal cerclage: a comparison of obstetric outcomes with either transabdominal or transvaginal cerclage. Am J Obstet Gynaecol 2000;183:836-9.
17. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thorn EA, Ernest JM, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000;342:534-40.
18. Odendaal HJ, Popov I, Schoeman J, Smithy M, Grove D. Preterm labour - is bacterial vaginosis involved? S Afr Med J 2002;92:231-4.
19. Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet 2003;361:983-88.
20. Kenyon SL, Taylor DJ, Tarnow-Mordi W, for the ORACLE Collaborative Group. Broad-spectrum antibiotics riot preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 2001;357:979-88.
21. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379-85.
22. Da Fonesca EB, Bittar RE, Carvalho MHB, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomised placebo-controlled double blind study. Am J Obstet Gynecol 2003;188:419-24.
23. Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials in Pregnancy (FOTIP) Team. Br J Obstet Gynaecol 2000;107:382-95.
24. Shah NR, Bracken MB. A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. Am J Obstet Gynecol 2000;182:465-72.
25. Hannah ME, Hannah WJ, Hewson SA, Hodnett ED, Saigal S, Willan AR, for the Term Breech Trial Collaborative Group. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Lancet 2000;356:1375-83.
26. Hofmeyr GJ, Hannah ME. Planned caesarean section for term breech delivery. Cochrane Database Syst Rev 2002;(2):CD000184.
27. Hofmeyr GJ, Kulier R. External cephalic version for breech presentation at term. Cochrane Database Syst Rev 2002;(2):CD000184.
28. Shennan A, Bewley S. How to manage term breech deliveries. BMJ 2001;323:244-5.
29. Impey L, O'Herlihy C. First delivery after cesarean delivery for strictly defined cephalopelvic disproportion. Obstet Gynecol 1998;92:799-803.
30. Esposito MA, Menihan CA, Malee MP. Association of interpregnancy interval with uterine scar failure in labor: a case-control study. Am J Obstet Gynecol 2000;183:1180-3.
31. Zelop CM, Shipp TD, Repke JT, Cohen A, Lieberman E. Effect of previous vaginal delivery on the risk of uterine rupture during a subsequent trial of labor. Am J Obstet Gynecol 2000;183:1184-6.
32. Sims EJ, Newman RB, Hulsey TC. Vaginal birth after cesarean: to induce or not to induce. Am J Obstet Gynecol 2001;184:1122-4.
33. Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP. Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med 2001;345:3-8.
34. Howell CJ. Epidural versus non-epidural analgesia for pain relief in labour. Cochrane Database Syst Rev 2000;(2):CD000331.
35. Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a randomised controlled trial. Lancet 2001;358:19-23.